Treatment of hepatitis C is rapidly changing. It began with IFN monotherapy; then the addition of ribavirin doubled the rate of response and pegylation of IFN further improved it. The development of direct-acting antivirals has brought up combinations of even three or more drugs with the aim of reaching the 100% response rate. However, the development of potent direct-acting antivirals with high barrier to resistance gives the possibility of reaching this aim with just two drugs. This review will focus on dual therapy moving on from the past to the near future.

The future of dual therapy for hepatitis C virus / Francesco Azzaroli;Marco Montagnani;Alberto Porro;Domenico Fiorillo;Giuseppe Mazzella. - In: FUTURE VIROLOGY. - ISSN 1746-0794. - STAMPA. - 9:(2014), pp. 905-912. [10.2217/fvl.14.78]

The future of dual therapy for hepatitis C virus

Francesco Azzaroli
Conceptualization
;
Marco Montagnani
Supervision
;
Alberto Porro
Membro del Collaboration Group
;
Giuseppe Mazzella
Conceptualization
2014

Abstract

Treatment of hepatitis C is rapidly changing. It began with IFN monotherapy; then the addition of ribavirin doubled the rate of response and pegylation of IFN further improved it. The development of direct-acting antivirals has brought up combinations of even three or more drugs with the aim of reaching the 100% response rate. However, the development of potent direct-acting antivirals with high barrier to resistance gives the possibility of reaching this aim with just two drugs. This review will focus on dual therapy moving on from the past to the near future.
2014
The future of dual therapy for hepatitis C virus / Francesco Azzaroli;Marco Montagnani;Alberto Porro;Domenico Fiorillo;Giuseppe Mazzella. - In: FUTURE VIROLOGY. - ISSN 1746-0794. - STAMPA. - 9:(2014), pp. 905-912. [10.2217/fvl.14.78]
Francesco Azzaroli;Marco Montagnani;Alberto Porro;Domenico Fiorillo;Giuseppe Mazzella
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/414366
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact